Halozyme Therapeutics (HALO) Goodwill & Intangibles (2022 - 2026)
Halozyme Therapeutics (HALO) recorded Goodwill & Intangibles of $1.5 billion in Q2 2026, up 92.1% from $783.13 million a year earlier but down 2.0% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Goodwill & Intangibles (2022 - 2026) Analysis & Trends
At the end of FY2025, Halozyme Therapeutics reported Goodwill & Intangibles of $1.56 billion, up 90.8% from FY2024.
- Annual Goodwill & Intangibles has a three-year compound annual growth rate of 17.8% (FY2022 to FY2025).
- Across earlier years, Goodwill & Intangibles came in at $818.65 million in FY2024 (-8.0%), $889.7 million in FY2023 (-6.9%) and $955.7 million in FY2022.
- Quarterly Goodwill & Intangibles has ranged from $765.37 million in Q3 2025 to $1.56 billion in Q4 2025 over the past five years.
- On a year-over-year basis, Goodwill & Intangibles has increased for three consecutive quarters, with growth averaging 29.2% over the last eight quarters.
- Peak year-over-year performance for Goodwill & Intangibles in the last five years was growth of 92.1% in Q2 2026, against a decline of 21.1% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.53 billion (Q1 2026), $1.56 billion (Q4 2025) and $765.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Halozyme Therapeutics | 12.53 Bn | 11.13 Bn | 401.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.50 Bn |
| Mar 31, 2026 | 1.53 Bn |
| Dec 31, 2025 | 1.56 Bn |
| Sep 30, 2025 | 765.37 Mn |
| Jun 30, 2025 | 783.13 Mn |
| Mar 31, 2025 | 800.89 Mn |
| Dec 31, 2024 | 818.65 Mn |
| Sep 30, 2024 | 836.41 Mn |
| Jun 30, 2024 | 854.18 Mn |
| Mar 31, 2024 | 871.94 Mn |
| Dec 31, 2023 | 889.70 Mn |
| Sep 30, 2023 | 907.46 Mn |
| Jun 30, 2023 | 927.80 Mn |
| Mar 31, 2023 | 945.04 Mn |
| Dec 31, 2022 | 955.70 Mn |
| Sep 30, 2022 | 1.15 Bn |
| Jun 30, 2022 | 1.18 Bn |
API Access
Halozyme Therapeutics Goodwill & Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=goodwill-and-intangibles&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "goodwill-and-intangibles", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=goodwill-and-intangibles&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();